Effect of High Dose Insulin on Infectious Complications Following Major Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

Despite improvements in surgical techniques and perioperative care, the high incidence of postoperative surgical site infections remains a major problem in patients undergoing major abdominal surgery (liver, pancreatic and colorectal surgery).

Using the hyperinsulinemic-normoglycemic clamp technique, i.e. continuous infusion of insulin combined with dextrose titrated to "clamp" blood glucose between 4 and 6 mmol/L, we successfully established and preserved normoglycemia during the perioperative period. Our objective of this study is to determine if the maintenance of perioperative normoglycemia by a hyperinsulinemic normoglycemic clamp reduces the rates of incisional and space/ surgical site infections following abdominal surgery (liver, pancreatic and colorectal surgery).

Eligibility criteria

Qualifiers

> 18 years old

elective liver, pancreatic or colorectal surgery

ability to give informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Hyperinsulinemic normoglycemic clamp
  • Standard glucose management

Treatment groups

460 Participants
are divided into 2 treatment groups

Locations

3
Canada
Royal Victoria HospitalH3A1A1, MontrealQuebec, Canada
Royal Victoria Hospital, McGill University Health CentreH3A 1A1, MontrealQuebec, Canada
Chile
Hospital Clinico Universidad de Chile8380456, IndependenciaSantiago Metropolitan, Chile

Sponsors and collaborators

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead sponsor